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ABSTRACT 
Stress granules (SGs) are cytoplasmic aggregates of mRNA and protein that form 
in response to environmental stress and are thought to confer protection from apoptosis. 
Bisphenol-A (BPA) is a ubiquitous environmental toxin linked to numerous diseases, 
though its relationship to SGs was previously unknown. BPA exposures within human 
serum levels had no significant effect on cell growth nor induced SG formation. 
However, high-dose acute BPA exposure greatly induced SG formation. Further, low-
dose chronic BPA exposure resulted in a significant decrease in SG formation during 
subsequent high-dose acute BPA exposure, suggesting that chronic exposure to BPA 
alters cellular stress dynamics. Our results suggest that BPA may seriously alter the 
ability of cells to cope with environmental stress. 
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Stress Granules 
Nover et al first discovered stress granules in heat shocked tomato cells in 1988 
(Nover et al., 1989).  Stress granules are cytoplasmic RNA-protein complexes containing 
non-translating mRNAs, translation initiation components, and many additional proteins 
affecting mRNA function that occur when a eukaryotic cell undergoes stress (Buchan and 
Parker, 2009). Stress granules are sites of mRNA triage at which mRNP complexes are 
monitored for integrity and composition and are then routed to sites of re-initiation, 
degradation, or storage (Kedersha and Anderson, 2002). The formation of stress granules 
allows the cell to focus its energy and resources on translating proteins necessary for 
survival by silencing translation of non-essential proteins. An example of this could be 
the increased translation of heat-shock proteins during an acute exposure to high 
temperature. These heat-shock proteins would prevent the denaturing of other proteins 
within the cell increasing the cell’s likelihood for survival.    
Composition of Stress Granules  
Stress granules are primarily composed of 48s pre-initiation complexes: such as, 
eIF3, eIF4E, and eIF4G. These complexes contain bound mRNA which are derived from 
disassembling polysomes. Figure 2 below diagrams the stress granule formation cycle as 
well as the relationship between stress granules and processing bodies (Kedersha et al., 
2005c). The components that make up stress granules include poly (A)+ RNA bound to 
early initiation factors, which regulate translation initiation on stress granule-associated 
transcripts (Anderson & Kedersha 2006). In an experiment with CV-1 cells treated with 
sodium arsenite, it was observed that the different components of the stress granule were 
equally distributed through the cytoplasm and nucleoplasm prior to the sodium arsenite 
treatment. Once under an acute stress, caused by sodium arsenite, the microtubules within 
the cell maneuver stress granule components together resulting in the initiation of stress 
granule formation. The experimental evidence presented shows nocodazole treatment 
disrupts microtubule formation which then prevents stress granule formation at the 
specific stress site (Ivanov et al., 2003). 
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Figure 2: Stress Granule Formation Cycle (Kedersha et al., 2005c) 
 
Functional Mechanism of Stress Granules  
When the cell is under environmental stress, such as arsenite treatment, it will 
exhibit phosphorylation of the eIF2(alpha) complex. This will arrest protein translation 
by lowering the availability of the ternary complex, eIF2-GTP-tRNAiMet, thus leading to 
an increase in untranslated mRNA. These untranslated mRNAs are then processed by 
stress granules (Ivanov et al., 2003). It is suggested that the primary functions of stress 
granules include the degradation, storage, and translation of mRNA. It is proposed that 
stress granules form to regulate translation in cells that are under stressed conditions in 
order to up-regulate the translation of proteins necessary for survival while 
simultaneously down-regulating the translation of housekeeping and non-essential 
mRNAs (Kedersha et al., 2002).  
Arsenic Induction of Stress Granules 
 Arsenic is an element in group V of the periodic table of elements. It has five 
valence electrons which results in it being highly reactive. In the atmosphere, arsenic acts 
as an oxidizing agent when heated. Initially arsenic was used for applications such as 
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wood preservation because it was found to be an effective insecticide. Eventually, it was 
realized that arsenic was more toxic than initially thought.  Chronic exposure to inorganic 
arsenic has been linked to skin, lung and bladder cancer. There has also been evidence 
that arsenic exposure may lead to liver and prostate cancer, diabetes, cardiac disorders, 
and neurological problems. Studies have shown a strong correlation between arsenic 
exposure and cancer incidence (Hong et al., 2014). 
With this view of arsenic as a toxin, it has been used commercially for 
applications like rat poisons and insecticides. Many researchers have looked into the 
impact arsenic has at a cellular level. Bhattacharya and Bhattacharya studied the effect of 
arsenic in nonlethal doses on Clarias batrachus (Indian catfish) and observed the impact 
on cellular processes by measuring the change in the level of byproducts. They found that 
a nonlethal dose of arsenic "induced tissue lipid peroxidation, increased the ratio of 
oxidized to reduced glutathione and produced excess H2O2 within 1–2 days of exposure" 
(Bhattacharya and Bhattacharya, 2007). Their study also showed arsenic treatment to 
impact the activity of glutathione peroxidase, superoxide dismutase, catalase, and 
glutathione reductase. The resulting fluctuations in these enzyme levels indicates 
oxidative stress. This was found to be reversible by pretreatment with N-acetylcysteine 
which could indicate the oxidative stress is caused by the excess H2O2 production 
(Bhattacharya and Bhattacharya, 2007). 
Oxidative stress interferes with the normal redox state of the cell. This includes 
the level of redox intermediates as well as enzymes involved with redox reactions. When 
a cell is experiencing oxidative stress they produce excess peroxides which they cannot 
readily break down. These peroxides damage cellular components such as proteins and 
DNA. The resulting DNA damage, if not repaired immediately, can lead to apoptosis or 
cellular transformation. An imbalance of the redox state of a cell will also interfere with 
signal transduction. The interference with cell signaling can disrupt many processes 
within the cell. Oxidative stress has been hypothesized to have involvement in the 
development of various diseases including cancer (Suzuki et al., 2008). 
Various studies have shown that arsenic induces cytoplasmic granules, for 
example Figure 3 shows the formation of stress granules in U2OS cells after arsenite 
treatment (Kedersha et al., 2005). The stress granules are forming in response to the 
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oxidative stress caused by arsenic. Since the stress caused by arsenic has been shown to 
be measurable in these two different ways (quantification of oxidation related molecule 
levels and stress granule formation) it may be possible to quantify the stress caused by 
other environmental toxins by these two methods (Jacobson et al., 2012). 
                                     
Figure 3: Stress Granule Formation After 30 Minute Arsenite Treatment 
(Kedersha et al., 2005) 
Bisphenol-A 
Bisphenol-A (BPA), 2,2-bis(4-hydroxyphenyl)propane, is a chemical made by 
combining acetone and phenol that is used primarily to produce polycarbonate plastics 
and epoxy resins (Kang et al., 2006). Polycarbonate plastics are utilized in the production 
of baby bottles, reusable plastic bottles, plates, cups, microwave ovenware, and storage 
containers. Epoxy resins are used for the internal coating of food and beverage cans 
(Geens et al., 2011). The prevalence of BPA in food storage containers contaminates the 
food, which leads to the unintentional human consumption of BPA. BPA is also found in 
thermal printed-paper, which is typically used in sales receipts, meaning that skin is 
another avenue of human exposure to BPA (Biedermann et al., 2010). BPA is one of the 
highest volume chemicals produced worldwide -- an estimated 6 billion pounds are 
produced annually-- and this production releases over 100 tons into the atmosphere 
(Vandenberg et al., 2007). BPA has been found in bodies of water, soil, and the air 
surrounding factories and hazardous waste landfills (Kang et al., 2006).  
Human BPA Exposure Levels  
Numerous studies have been conducted in order to quantify the average level of 
exposure of humans to BPA. Studies have revealed that BPA can be measured in the 
serum, urine, amniotic fluid, follicular fluid, placental tissue, and umbilical cord blood of 
humans, most likely as a result of exposure to BPA through the aforementioned products 
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and environmental exposures(Vandenberg et al., 2007). The average level of BPA in 
healthy human serum, as determined by a 2000 study, is 1.40nM (Inoue et al., 2000). 
Numerous studies have found that the daily human intake of BPA is <1μg/kg body 
weight/day (Bolt et al., 2001). Although this is considerably lower than the no-observed-
adverse-effect level (NOAEL) of 5 mg/kg body weight/day, concern has been raised by 
several studies that suggests levels as low as about 0.21μg/kg body weight/day can cause 
health problems (Kang et al., 2006;Vandenberg et al., 2007).  
Deleterious Effects of BPA  
 The levels of BPA found in human tissue have raised concern because BPA is 
considered an endocrine disrupting chemical. Endocrine disrupting chemicals interfere 
with the endocrine system, which is a collection of glands that secrete hormones to 
regulate various body functions such as reproduction, growth and development, 
maintenance of electrolytes, water, and nutrient balance of the blood, regulation of 
cellular metabolism and energy balance, and mobilization of body defense (Marieb & 
Hoehn, 2012).  
 BPA mimics the hormone estrogen in humans and has a weak affinity for binding 
to estrogen receptors (Vandenberg et al., 2007). The estrogen mimicking property of BPA 
was discovered accidentally by Krishnan et al. when BPA leached from autoclaved 
polycarbonate flasks increased the rate of proliferation of MCF-7 breast cancer cells 
(Krishnan et al., 1993). Further evidence of BPA’s affinity for binding to estrogen 
receptors can be seen when comparing the chemical structure of BPA to diethylstilbestrol 
(DES), which was a synthetic form of estrogen prescribed to pregnant woman between 
1940 and 1971 that was later found to cause cancer, birth defects, and other 
developmental abnormalities (Giusti et al., 1995). As shown below in Figure 4, BPA has 
a similar structure to DES, and although it is different from that of endogenous estradiol,  
it is still capable of binding both alpha and beta estrogen receptors (Vandenberg et al., 
2007).  
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In the context of our project, we aim to characterize the acute and adaptive 
cellular stress response to BPA exposure. We plan on accomplishing this through 
completing the following objectives:  
1.) To test if BPA levels similar to average human serum levels have an impact on 
cellular growth and stress granule formation.  
 
2.) To assess the impact of acute high-level BPA exposure on stress granule   
formation.  
 
3.) To analyze the impact of a chronic low-level BPA exposure on SG formation 
during a subsequent acute high-level BPA exposure, also known as an 
adaptive response. 
 
  In conjunction with these objectives, we hypothesized that the following 
outcomes would occur: 
1.) Chronic low-dose exposure to BPA will result in a decrease in cellular growth 
that is dose dependent. 
 
2.) Acute high-dose exposure to BPA will lead to the formation of stress granules. 
 
3.) Chronic low-dose exposure to BPA prior to an acute high-dose BPA exposure 
will decrease the amount of stress granule formation, also known as an 
adaptive response. 
 
This foundational knowledge could provide significant implications for the 
connection between BPA exposure and cellular apoptosis as well as BPA related disease 
states. Establishing this connection could raise awareness and help improve prevention 
practices for BPA exposure. 
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METHODS  
U2OS Cell Line   
U2OS is a human osteosarcoma cell line that was first cultured in 1964 from the 
tibia of a 15 year old female (Niforou et al., 2008). This adherent U2OS cell line was 
transfected with GFP-G3BP and then cloned (Kedersha et. al, 2008). G3BP is a 
phosphorylation-dependent endoribonuclease that localizes mRNA and regulates stress 
granule assembly (Tourrière et al., 2003). The GFP florescent tag helps to visualize the 
localization of G3BP for the identification of stress granule formation through 
microscopy. The U2OS GFP-G3BP cell line was a kind gift from Nancy Kedersha at 
Brigham and Women’s Hospital in Boston. This cell line is cultured in DMEM (Corning 
Cellgro) media with 10% FBS (Equitech) and 1% Penicillin/Streptomycin (Lonza) and 
incubated at 37°C with 5% CO2. The cultures are allowed to grow for 2-3 days then 
subcultured 1:3.  
BPA Survival Assay 
 1.0×105 U2OS cells were plated in each well of a six-well plate and grown for 48 
hours. A specific concentration of BPA (Aldrich Chemistry) was introduced to each well 
and the cells grew for an additional 24 hours in the incubator. The following 
concentrations of BPA diluted in cultured media were tested: 1.09nM, 2.19nM, 4.38nM, 
8.75 nM, 17.5nM. (The initial BPA stock used was dissolved in methanol at a diluted 
concentration of 0.1M.) At 24 hours, cells were treated with Trypsin-Versene, scraped, 
collected into an Eppendorf tube, dyed with 0.4% trypan blue and then the live cells were 
counted using a hemocytometer. To analyze the statistical significance of the data from 
this experiment we performed an ANOVA using Microsoft Excel. 
Acute Stress Response  
To induce stress granule formation in the U2OS cell line, various acute stress tests 
were performed. 7.0 × 104 U2OS cells were plated in each well of a twelve well plate on 
top of a coverslip that had been pretreated with 125µL of DMEM 1X+20% 
FBS+Pen/Strep media for 5 minutes. The cells grew for 48 hours in 1 mL of DMEM 
1X+10% FBS+Pen/Strep media in a 37ºC incubator. After this period of normal growth, 
a specific concentration of the stressor [either sodium arsenite (Aldrich Chemistry) or 
BPA (Aldrich Chemistry)] was introduced to each well and incubated for 1 hour. The 
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following concentration of sodium arsenite diluted in cultured media was utilized: 
500µM. The following concentrations of BPA diluted in cultured media were utilized: 
500µM, 400µM, 300µM, and 250µM. At the end of the 1-hour treatment, the treated 
media was aspirated off and the cover slips were covered in 1X PBS. The cells in each 
well were then fixed with paraformaldehyde, treated with 100% methanol, and the nuclei 
were subsequently stained with Hoechst 33342 (Life Technologies). The cover slips from 
each well were then mounted, cell side down, on labeled microscope slides utilizing 
polyvinyvl alcohol mounting media (Fukui et al., 1987).  
To quantify the formation of stress granules, a minimum of 100 cells were 
counted, and classified as either positive or negative for visible stress granules granule 
formation at 400X magnification on the Zeiss AXIO observer A1. Once a field of view 
was started, all the cells within it were counted. All images were captured using the 
SPOT Idea 5.0mp camera attached to the Zeiss AXIO observer A1 microscope. The 
images were taken using GFP and DAPI channels. The merges for our fluorescence 
microscopy images were made by overlaying the images obtained from these two 
channels using Adobe Photoshop. To analyze the statistical significance of the data from 
this experiment we performed an ANOVA as well as two-tailed T tests with 95% 
confidence for differences between groups using Microsoft Excel. 
Adaptive Stress Response    To test if exposure to a low BPA concentration makes an impact on stress granule 
formation in a later acute BPA exposure, an adaptive stress response experiment was 
performed. 7.0 X 104 U2OS-GFP-G3BP cells were plated in each well of a twelve-well 
plate on top of a coverslip, which had been pretreated with 125µL of DMEM 1X+20% 
FBS + Pen/Strep Media for five minutes. The cells grew for 24 hours in 1 mL of DMEM 
1X + 10% FBS+Pen/Strep media in a 37˚C incubator. Wells were then treated according 
to the chart in Table 1 (all BPA dilutions are in cultured media). The BPA treatments 
added at 24 hours stayed on the wells the remainder of the experiment while those added 
at 48 hours lasted 1 hour. The cells in each well were fixed with paraformaldehyde, then 
with 100% methanol and subsequently the nuclei were stained with Hoechst 33342 (Life 
Technologies). Each cover slip from the wells were mounted, cell-side down, onto a 
labeled microscope slide with polyvinyl alcohol mounting media (Fukui et al., 1987).  
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To quantify the formation of stress granules, a minimum of 100 cells were 
counted and classified as either positive or negative for stress granules at 400X 
magnification on the Zeiss AXIO observer A1. Once a field of view was started, all the 
cells within it were counted. All images were captured using the SPOT Idea 5.0mp 
camera attached to the Zeiss AXIO observer A1 microscope. The images were taken 
using GFP and DAPI channels. The merges for our fluorescence microscopy images were 
made by overlaying the images obtained from these two channels using Adobe 
Photoshop. To analyze the statistical significance of the data from this experiment we 
performed an ANOVA as well as a one-tailed T test with 95% confidence using 
Microsoft Excel. 
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RESULTS 
Sodium Arsenite Acute Stress Response 
To ensure our U2OS GFP-G3BP cell line enabled us to visualize stress granule 
formation, the cells were grown on coverslips in a 12 well plate for 48 hours and then 
treated with 500µM sodium arsenite for 1 hour, which is a condition that has previously 
been shown to form stress granules (Kedersha et al., 2005a).  After the 1-hour exposure, 
the cells were fixed, the nuclei were stained with Hoechst 33342, and coverslips were 
mounted on slides using polyvinvyl mounting media. Figure 5 shows the sodium arsenite 
treated cells at 630X total magnification.  
Figure 5: 630X total magnification of U20S GFP-G3BP cell(s) after 1 hour exposure 
to 500µM sodium arsenite. White Arrows indicate the site of stress granules. 
 
As shown in Figure 5, the 1-hour exposure to 500µM sodium arsenite did in fact 
induce stress granule formation in 92% of U2OS GFP-G3BP cells, as reported 
previously.  
BPA Survival Assay  
In order to test the effect of varying concentrations of BPA on U2OS cell growth, 
1.0×105 U2OS GFP-G3BP cells were plated in each well of a six well plate. After 48 
hours of normal growth, wells were treated with the following concentrations of BPA: 
1.09 nM, 2.19nM, 4.38nM, 8.75nM, 17.5nM and the last well was left untreated to act as 
a control. After a 24-hour exposure, each well was trypsinized and cell counts were 
performed to quantify the number of remaining live cells. Counts revealed that all 6 wells 
underwent cell growth and ended with more cells than had been originally plated, which 
can be seen in Supplemental Data (Tables S1). The cell counts were normalized to the 
cell growth of the untreated well within each trial. These normalized values from each of 
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treated with each of the following concentrations of BPA for 1 hour: 500µM, 400µM, 
300µM, 250µM with two wells left untreated. Cells were counted under the 40X 
objective (400X total magnification) and classified as either positive or negative for 
visible stress granules.  The results of these counts, including number of total cells, 
number of cells with stress granules, and percent maximal stress granule formation for 
each trial (n=4) was tabularized and can be found in Supplemental Data (Tables S2). 
Percent maximal stress granule formation is a normalization of values in each trial to the 
maximum percent of stress granule formation obtained in that trial. The normalized 
values from the four trials were averaged and the mean values were graphed with 
standard error bars (Figure 7).   
 
 
Figure 7: Effects of Various Concentrations of BPA on Stress Granule 
Formation During Acute Exposure. Numbers shown represent the mean percent of 
cells showing stress granule formation relative to the maximum number of stress granules 
formed during the trial from four separate trials with standard error. The p-value from the 
ANOVA for this data set was 2.65 X 10-5. 
 
The control, which received no treatment, consistently showed minimal stress 
granule formation. The 250µM treatment showed consistent low levels of stress granule 
formation. This can be observed in the graph as the data shows approximately 9% 
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maximal stress granule formation with a small error bar ranging from 8-10%. The 300µM 
treatment showed moderate stress granule formation (55% maximal stress granule 
formation) but with a large error bar ranging from 30-80%. The 400µM BPA exposure 
showed consistently robust stress granule formation as indicated by the 100% maximal 
stress granule formation seen in the figure. The highest concentration exposure, 500µM 
BPA, showed 88% maximal stress granule formation with an error bar ranging from 82-
93% (Figure 7).  An ANOVA was performed on this data set and revealed a p-value of 
2.65 X 10-5. This p-value indicates the difference between the treatment groups is 
statistically significant. Two-tailed T-tests were also performed between the treatment 
groups to test for significance.  
BPA Adaptive Stress Response 
To test the adaptive stress response of U2OS-GFP-G3BP, cells were exposed to a 
low-level of BPA for 24 hours and then underwent a subsequent acute exposure of BPA 
for 1 hour. To do this, 7.0 X 104 U2OS-GFP-G3BP cells were plated on cover slips in a 
12-well plate and allowed to grow uninterrupted for 24 hours. The initial BPA treatment 
occurred at 24 hours and remained on the cells until the conclusion of the experiment 
while the second BPA treatment occurred at 48 hours for one hour. Wells were treated 
according to the following chart (all BPA dilutions are in cultured media):  
Table 1: Treatment Schedule for Adaptive Stress Response 
Treatment  BPA Treatment added 
at 24 hours 
BPA Treatment at 
48 hours 
No Treatment 0 0 
Acute  0 400 µM 
Chronic 4.38 nM 0 
Chronic & Acute 4.38 nM 400 µM 
  
Under the 40X objective (400X total magnification) cells were counted and 
classified as either positive or negative for visible stress granule formation.  The results 
of these counts, including total number of cells, number of cells with stress granules, and 
percent maximal stress granule formation for each trial (n=5) were tabularized and can be 
found in Supplemental Data (Tables S3). Percent maximal stress granule formation is a 
normalization of values in each trial to the maximum stress granule value obtained in that 
trial. 
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Photographs of a representative field from each treatment group were then taken 
using the 63X oil immersion object lens at 630X total magnification, and are shown in 
Figure 9.  
 
Figure 9: 630X total magnification of U20S GFP-G3BP cell(s) from the 
four experimental groups in the BPA Adaptive Stress Response. (A) 25 hour 
Chronic (4.38nM) & 1 hour Acute (400μM) BPA exposure, (B) 1 hour acute (400µM) 
BPA exposure (C) 25 hour exposure to chronic (4.38nM) BPA and (D) untreated. White 
arrows indicate stress granules.  
 
 As can be seen in the florescence microscopy images above, both the chronic & 
acute treatment group (A) as well as the acute treatment group (B) resulted in high stress 
granule formation while the 4.38 nM BPA exposure for 25 hours (C) along with the 
untreated cells (D) resulted in little to no stress granule formation.  
C 
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DISCUSSION 
Sodium Arsenite Acute Stress Response  
As a positive control, a 500µM sodium arsenite 1-hour exposure was performed 
to ensure stress granule formation within the U2OS-GFP-G3BP cells could be visualized. 
Previous literature has shown that that stress granules should form in this particular cell 
line under these conditions (Kedersha et al., 2005b). Figure 5 shows that stress granules 
(indicated by arrows) did in fact form and were centralized around the nucleus as 
expected. These results showed our U2OS-GFP-G3BP cells allowed us to visually 
identify stress granules using fluorescence microscopy, which would allow us to test 
other environmental toxins (BPA) for the formation of stress granules. 
BPA Survival Assay  
In order to ascertain how exposure to BPA would affect the growth of U2OS 
GFP-G3BP cells, a survival assay was performed. The concentrations chosen were 
physiologically relevant, and included the range of BPA reported to be in average healthy 
human serum. It was hypothesized that chronic low-dose exposure to BPA would cause a 
decrease in cellular growth in a dose-dependent manner. The percent control data shown 
in Figure 6 shows that the lower concentrations, 1.09nM, 2.19nM and 4.38nM, had live 
cell counts that were higher than the control plate. However, as the concentration of BPA 
increased, the growth of the cells declined linearly from 140 percent control to 85 percent 
control. While these differences were not statistically significant, there was an apparent 
trend with proliferation at lower doses. Our cell counting method is a potential source of 
some variability in the data, so in order to validate this data we suggest repeating this 
experiment with a more accurate assay. A few examples of more accurate, non-biased, 
cell counting assays are MTT or crystal violet staining.   
A potential spike in growth at the lower concentrations of BPA could be 
attributed to a biphasic dose response. This is when a low-level exposure to an 
environmental toxin has the opposite effect on cells as it does during a high-level 
exposure (Calabrese, 2013). The cell growth at lower levels of BPA exposure suggests 
that BPA could be interfering with cell signaling resulting in inappropriate cellular 
growth. This finding is especially important because it may account for some of the 
correlation between BPA exposure and diseases such as cancer and reproductive 
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disorders. The cell growth begins to decline at the higher concentrations of BPA most 
likely because the BPA is becoming too toxic to the cells and they are no longer able to 
grow. 
BPA Acute Stress Response 
After observing the effect of physiologically relevant BPA levels on cell growth, 
the next experiment was to test if an acute exposure to BPA was capable of inducing 
stress granules. Originally we used a BPA exposure of only 30 minutes, but that exposure 
time resulted in a very small number of cells with stress granules, so we increased the 
exposure time to 1 hour. It was hypothesized that acute high-dose exposure to BPA 
would result in the formation of stress granules. 
One hour of BPA exposure did in fact cause stress granule formation in the U2OS 
GFP-G3BP cell line. This can be seen in Figure 7. It is hypothesized that the formation 
of stress granules is caused by oxidative stress that BPA imposes on the cell because 
BPA has been shown to impact the levels of superoxide dismutase, catalase, 
glutathione reductase, and glutathione peroxidase, which are all important in the cell’s 
oxidative stress response (Chitra et al., 2003).  
The control, which received no treatment, consistently showed minimal stress 
granule formation. The 250µM treatment showed consistent low levels of stress granule 
formation. The 300µM treatment showed moderate stress granule formation (55% 
maximal stress granule formation). The 400µM BPA exposure showed consistently 
robust stress granule formation as indicated by the 100% maximal stress granule 
formation (Figure 7). The highest concentration exposure, 500µM BPA, also showed 
consistent robust stress granule formation. 
An ANOVA was performed on this data set and revealed a p-value of 2.65 X 10-5. 
This p-value indicates the difference between the treatment groups is statistically 
significant. The large error bar that accompanies the 300µM data suggests there may be a 
threshold for robust stress granule formation. Below this threshold some cells do begin to 
form stress granules but once this threshold is surpassed nearly all of the surviving cells 
form stress granules. This is supported by the data for the exposures above and below 
300µM. The 250µM exposure would be below this threshold and results in consistent low 
levels of stress granule formation. The 400µM exposure is above this threshold and leads 
 22 
to consistent high levels of stress granule formation. There is an apparent decrease in the 
percentage of cells forming stress granules during the 500µM exposure. However, the 
difference between 400µM and 500µM was not statistically significant as determined by 
a two-tailed T test with a p-value of 0.14.  
A possible explanation for this apparent decrease between 400µM and 500µM 
could be an upper toxicity limit for stress granule formation. The upper toxicity limit of 
stress granule formation would prevent futile stress granule formation when cells have 
reached the irreversible fate of apoptosis. This data shows that acute BPA exposure does 
result in stress granule formation that is dose dependent.  
BPA Adaptive Stress Response 
After testing the impact of physiologically relevant levels of BPA on cell growth 
as well as stress granule formation in response to acute high-dose BPA stress, the next 
step was to analyze the impact of a combination of the two. Thus, cells were treated with 
a chronic low-level of BPA for 24 hours followed by a one hour high-level BPA 
treatment. 4.38 nM was selected to be the chronic low-dose concentration of BPA 
because this was the BPA concentration in the middle of our survival assay range (Figure 
6). The acute BPA treatment concentration was chosen to be 400μM because it 
consistently formed the maximal number of stress granules in an acute 1-hour exposure 
(Figure 7).  
The hypothesis being tested was that a chronic low-dose exposure to BPA would 
decrease the amount of stress granule formation in a subsequent acute high-level BPA 
stress, known as an adaptive response. As can be seen in Figure 8, the hypothesis was 
confirmed and the experimental group that first received a chronic low-dose BPA 
exposure before a subsequent acute BPA exposure had significantly less stress granule 
formation (roughly 4% less) than the treatment group that only received the acute high-
dose exposure.  Significance was supported by a one-tailed T-test with 95% confidence 
that resulted in a p-value of 0.037.  
It is hypothesized that this decrease in stress granule formation could be attributed 
to the fact that the chronic low-level exposure to BPA elevates cells threshold for 
initiating a stress response. We believe the cells have adjusted their protein expression to 
acclimate to consistent low-level exposure to BPA which impacts later stress granule 
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formation. This adaptive response may prove detrimental because stress granules act to 
protect eukaryotic cells and decrease the chance of apoptosis (Arimoto et al., 2008). 
Thus, cells that are exposed to a chronic low level of BPA and have an adaptive response 
to a later acute high-level exposure to BPA would have a smaller number of stress 
granules and thus a greater potential for cell apoptosis.  
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CONCLUSIONS 
During our BPA survival assay our data showed BPA levels similar to average 
human serum levels (1.4nM) had no significant effect on cell growth and did not result in 
significant stress granule formation (Figure 6). However, we observed a possible dose-
dependent response to chronic exposure to physiologically relevant BPA levels on cell 
growth. In order to further investigate this chronic low-dose effect of BPA on cell 
growth, we suggest longer chronic exposure to our physiologically relevant BPA 
concentrations. This will allow for an amplification of the impact on cellular growth. We 
believe the lack of statistically significant differences between cell growths may have 
been due to a lack of ample time for these differences to manifest, and/or the limitations 
of the assay system used for the experiment. 
Our acute BPA stress response assay provided data that showed high-level acute 
BPA exposure caused a significant increase in stress granule formation when compared 
to untreated cells. It also revealed a possible threshold of robust stress granule formation 
(Figure 7). In order to further investigate this threshold of robust stress granule 
formation, we recommend repeating our acute exposure with various concentrations 
centralized around 300µM. We suggest starting at 250µM BPA and increasing by 25µM 
until 350µM BPA as a possible starting point. This should allow the dose-dependent 
threshold to be more accurately identified.  
Our final assay analyzed adaptive cellular stress response to BPA exposure. We 
found chronic-low level (4.38nM) BPA exposure resulted in a significant decrease in 
stress granule formation during a subsequent high-level (400µM) BPA exposure. In order 
to further investigate this phenomenon, we have a few suggested experiments. It is 
possible that during the adaptive stress response an increased number of cells are 
undergoing apoptosis because they are not forming adequate stress granules.  This would 
decrease the number of cells negative for stress granule formation therefore increasing 
the overall percentage of cells positive for stress granule formation. In order to see if this 
is happening, a cytochrome stain could be used to identify the number of cells 
undergoing apoptosis during both the acute and the chronic & acute treatment. Another 
continuation of our experiment would be to increase the chronic exposure time to see if 
longer chronic low-dose BPA exposure would further decrease the stress granule 
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formation during subsequent high-dose acute BPA exposure. Additionally, if a more 
specific threshold for robust stress granule formation during acute BPA exposure is 
identified, this can be used in the adaptive stress response assay. By using concentrations 
just below the robust stress granule formation threshold the adaptive stress response can 
be further analyzed to see if this threshold is actually increased during an adaptive stress 
response. Lastly, one more future experiment could be to change the secondary acute 
stress to see if chronic low-dose exposure to BPA has an impact on the cellular stress 
response during acute exposure to other cellular stressors, such as arsenic.  
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SUPPLEMENTAL DATA 
 The following tables include the raw data from all the experiments performed. To 
review the methods used to collect this data, please refer to the Methodology Section of 
this paper.  
Tables S1: BPA Survival Assay Raw Data 
Table S1.1: BPA Survival Assay Trial 1 
BPA Concentration (nM) 
Live Cell Concentration Per Well 
(cells/mL) 
Percent Control 
17.5 1.165 X 106 88.9 
8.75 1.55 X 106 118.3 
4.38 2.37 X 106 180.9 
2.19 2.22 X 106 169 
1.09 2.66 X 106 203 
0 1.31 X 106 100 
 
Table S1.2: BPA Survival Assay Trial 2 
BPA Concentration (nM) 
Live Cell Concentration Per Well 
(cells/mL) 
Percent Control 
17.5 7.432 X 105 72.5 
8.75 9.334 X 105 91.1 
4.38 1.12 X 106 109.3 
2.19 1.175 X 106 114.6 
1.09 1.365 X 106 133.2 
0 1.025 X 106 100 
 
Table S1.3: BPA Survival Assay Trial 3 
BPA Concentration (nM) 
Live Cell Concentration Per Well 
(cells/mL) 
Percent Control 
17.5 3.84 X 105 49 
8.75 6.5 X 105 82.9 
4.38 7.155 X 105 91.3 
2.19 8.73 X 105 111.4 
1.09 9.63 X 105 122.8 
0 7.84 X 105 100 
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Table 1.4: BPA Survival Assay Trial 4 
BPA Concentration (nM) 
Live Cell Concentration Per Well 
(cells/mL) 
Percent Control 
17.5 3.95 X 105 77.1 
8.75 4.42 X 105 86.3 
4.38 4.98 X 105 97.3 
2.19 4.233 X 105 82.7 
1.09 4.167 X 105 81.4 
0 5.12 X 105 100 
 
Table S1.5: BPA Survival Assay Trial 5 
BPA Concentration (nM) 
Live Cell Concentration Per Well 
(cells/mL) 
Percent Control 
17.5 1.11 X 106 142.3 
8.75 9.03 X 105 115.8 
4.38 1.0 X 106 128.2 
2.19 1.08 X 106 138.5 
1.09 1.27 X 106 162.8 
0 7.8 X 105 100 
 
Tables S2: BPA Acute Stress Response Raw Data   
Table S2.1: BPA Acute Stress Response Trial 1 
Concentration 
(µM) 
Stress 
Granules 
Count 1 
Total 
Count 1 
Stress 
Granules 
Count 2 
Total 
Count 2 
Average % 
of Stress 
Granules 
Percent 
Maximal 
Stress 
Granules 
500 125 170 96 152 68.63354037 71.70341119 
400 197 209 116 118 95.71865443 100 
300 125 134 155 167 93.02325581 97.18404042 
250 6 141 8 170 4.501607717 4.702957583 
0 1 141 1 122 0.760456274 0.794470293 
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Table S2.2: BPA Acute Stress Response Trial 2 
Concentration 
(µM) 
Stress 
Granules 
Count 1 
Total 
Count 1 
Stress 
Granules 
Count 2 
Total 
Count 2 
Average % 
of Stress 
Granules 
Percent 
Maximal 
Stress 
Granules 
500 80 102 112 138 80 87.63485477 
400 131 138 110 126 91.28787879 100 
300 118 130 169 189 89.96865204 98.55487194 
250 0 145 3 127 1.102941176 1.208201122 
0 1 125 1 104 0.873362445 0.956712388 
 
Table S2.3: BPA Acute Stress Response Trial 3 
Concentration 
(µM) 
Stress 
Granules 
Count 1 
Total 
Count 1 
Stress 
Granules 
Count 2 
Total 
Count 2 
Average % 
of Stress 
Granules 
Percent 
Maximal 
Stress 
Granules 
500 163 171 106 110 95.72953737 100 
400 126 136 141 145 95.01779359 99.25650557 
300 40 148 24 115 24.33460076 25.42015916 
250 10 142 7 132 6.204379562 6.481154858 
0 1 112 0 112 0.446428571 0.4663436 
 
 
Table S2.4: BPA Acute Stress Response Trial 4 
Concentration 
(µM) 
Stress 
Granules 
Count 1 
Total 
Count 1 
Stress 
Granules 
Count 2 
Total 
Count 2 
Average % 
of Stress 
Granules 
Percent 
Maximal 
Stress 
Granules 
500 121 127 106 125 90.07936508 91.36011435 
400 100 102 111 112 98.59813084 100 
300 0 104 1 167 0.36900369 0.374250188 
250 0 127 0 183 0 0 
0 1 157 0 136 0.341296928 0.346149491 
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Tables S3: BPA Adaptive Stress Response Raw Data 
Table S3.1: BPA Adaptive Stress Response Trial 1 
 
Table S3.2: BPA Adaptive Stress Response Trial 2 
 
Table S3.3: BPA Adaptive Stress Response Trial 3 
 
 
Condition 
Stress 
Granules 
Count 1 
Total 
Count 1 
Stress 
Granules 
Count 2 
Total 
Count 2 
Stress 
Granules 
Count 3 
Total 
Count 3 
Average % 
of Stress 
Granules 
Percent 
Maximal 
Stress 
Granules 
Chronic 2 116 1 111 0 127 0.847457627 0.860848605 
Chronic and 
Acute 227 248 139 154 205 216 92.39482201 93.85478533 
Acute 154 155 155 157 134 138 98.44444444 100 
Negative 
Control 3 108 4 150 2 125 2.349869452 2.387000572 
Condition 
Stress 
Granules 
Count 1 
Total 
Count 1 
Stress 
Granules 
Count 2 
Total 
Count 2 
Stress 
Granules 
Count 3 
Total 
Count 3 
Average % 
of Stress 
Granules 
Percent 
Maximal 
Stress 
Granules 
Chronic 2 104 1 105 3 108 1.892744479 1.950626574 
Chronic and 
Acute 100 106 105 118 89 104 89.63414634 92.37525173 
Acute 128 129 97 105 102 103 97.03264095 100 
Negative 
Control 0 113 0 121 2 112 0.578034682 0.595711584 
Condition 
Stress 
Granules 
Count 1 
Total 
Count 1 
Stress 
Granules 
Count 2 
Total 
Count 2 
Stress 
Granules 
Count 3 
Total 
Count 3 
Average % 
of Stress 
Granules 
Percent 
Maximal 
Stress 
Granules 
Chronic 1 106 2 100 1 128 1.19760479 1.399375163 
Chronic and 
Acute 106 129 91 122 94 110 80.60941828 94.19035288 
Acute 104 116 140 168 124 146 85.58139535 100 
Negative 
Control 4 161 1 146 4 101 2.205882353 2.577525575 
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Table S3.4: BPA Adaptive Stress Response Trial 4 
 
Table S3.5: BPA Adaptive Stress Response Trial 5 
 
 
 
 
  
Condition 
Stress 
Granules 
Count 1 
Total 
Count 1 
Stress 
Granules 
Count 2 
Total 
Count 2 
Stress 
Granules 
Count 3 
Total 
Count 3 
Average % 
of Stress 
Granules 
Percent 
Maximal 
Stress 
Granules 
Chronic 0 122 1 145 3 138 0.987654321 1.012040847 
Chronic and 
Acute 126 129 160 162 119 124 97.59036145 100 
Acute 100 101 124 126 112 118 97.39130435 99.79602791 
Negative 
Control 0 108 0 114 2 133 0.563380282 0.577290906 
Condition 
Stress 
Granules 
Count 1 
Total 
Count 1 
Stress 
Granules 
Count 2 
Total 
Count 2 
Stress 
Granules 
Count 3 
Total 
Count 3 
Average % 
of Stress 
Granules 
Percent 
Maximal 
Stress 
Granules 
Chronic 2 146 3 131 0 132 1.222493888 1.26573322 
Chronic and 
Acute 111 116 0 0 130 134 96.4 99.8096463 
Acute 105 113 104 105 102 104 96.58385093 100 
Negative 
Control 3 128 0 145 1 119 1.020408163 1.05649977 
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